A detailed history of Washington Trust Advisors, Inc. transactions in Penumbra Inc stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 20,965 shares of PEN stock, worth $4.07 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
20,965
Previous 4,996 319.64%
Holding current value
$4.07 Million
Previous $1.12 Million 238.39%
% of portfolio
0.36%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$172.27 - $223.95 $2.75 Million - $3.58 Million
15,969 Added 319.64%
20,965 $3.77 Million
Q4 2023

Jan 18, 2024

BUY
$181.44 - $260.22 $530,712 - $761,143
2,925 Added 141.24%
4,996 $1.26 Million
Q3 2023

Oct 18, 2023

BUY
$240.69 - $338.77 $498,468 - $701,592
2,071 New
2,071 $500,000
Q4 2022

Feb 08, 2023

SELL
$151.88 - $228.5 $174,662 - $262,775
-1,150 Reduced 20.5%
4,460 $991,000
Q2 2022

Jul 25, 2022

BUY
$116.09 - $227.33 $651,264 - $1.28 Million
5,610 New
5,610 $698,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $7.36B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.